Global Equine Influenza Vaccine Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Equine Influenza Vaccine Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Report Code: KNJ1408852 | No. of Pages: 76 | Category: Pharmaceuticals and Healthcare
Publisher: Maia Research | Date of Publish: Sep-2022
Market Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Equine Influenza Vaccine estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

North American market for Equine Influenza Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Equine Influenza Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Europe market for Equine Influenza Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Equine Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Influenza Vaccine.

The Equine Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Equine Influenza Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Equine Influenza Vaccine segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

Zoetis

Merck Animal Health

Boehringer Ingelheim Vetmedica

Equine Influenza Vaccine Segment by Type

Liquid

Powder

Equine Influenza Vaccine Segment by Application

Home

Pet Clinic

Others

Equine Influenza Vaccine Segment by Region

North America (USA and Canada)

Europe (Germany, the U.K., France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Mexico, Brazil, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Equine Influenza Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

Informative and detailed data, sales, revenue, average price, historical and forecast data, which is analyzed to tell you why your market is set to change. Provision of market value (USD million) data for each segment and sub-segment.

This report will help stakeholders to understand the global industry status and trends of Equine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities. This enables you to anticipate market changes to remain ahead of your competitors.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly.

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Equine Influenza Vaccine industry. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by type, market size by type for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Equine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Equine Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by application, market size by application for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Findings and Conclusion
1 Equine Influenza Vaccine Market Overview

1.1 Equine Influenza Vaccine Product Overview

1.2 Equine Influenza Vaccine Market Segment by Type

1.2.1 Liquid

1.2.2 Powder

1.3 Global Equine Influenza Vaccine Market Size by Type

1.3.1 Global Equine Influenza Vaccine Market Size Overview by Type (2017-2028)

1.3.2 Global Equine Influenza Vaccine Historic Market Size Review by Type (2017-2022)

1.3.2.1 Global Equine Influenza Vaccine Sales Breakdown in Volume by Type (2017-2022)

1.3.2.2 Global Equine Influenza Vaccine Sales Breakdown in Value by Type (2017-2022)

1.3.2.3 Global Equine Influenza Vaccine Average Selling Price (ASP) by Type (2017-2022)

1.3.3 Global Equine Influenza Vaccine Forecasted Market Size by Type (2023-2028)

1.3.3.1 Global Equine Influenza Vaccine Sales Breakdown in Volume by Type (2023-2028)

1.3.3.2 Global Equine Influenza Vaccine Sales Breakdown in Value by Type (2023-2028)

1.3.3.3 Global Equine Influenza Vaccine Average Selling Price (ASP) by Type (2023-2028)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Equine Influenza Vaccine Sales Breakdown by Type (2017-2022)

1.4.2 Europe Equine Influenza Vaccine Sales Breakdown by Type (2017-2022)

1.4.3 Asia-Pacific Equine Influenza Vaccine Sales Breakdown by Type (2017-2022)

1.4.4 Latin America Equine Influenza Vaccine Sales Breakdown by Type (2017-2022)

1.4.5 Middle East and Africa Equine Influenza Vaccine Sales Breakdown by Type (2017-2022)

2 Global Equine Influenza Vaccine Market Competition by Company

2.1 Global Top Players by Equine Influenza Vaccine Sales (2017-2022)

2.2 Global Top Players by Equine Influenza Vaccine Revenue (2017-2022)

2.3 Global Top Players Equine Influenza Vaccine Price (2017-2022)

2.4 Global Top Manufacturers Equine Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type

2.5 Equine Influenza Vaccine Market Competitive Situation and Trends

2.5.1 Equine Influenza Vaccine Market Concentration Rate (2017-2022)

2.5.2 Global 5 and 10 Largest Manufacturers by Equine Influenza Vaccine Sales and Revenue in 2021

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Influenza Vaccine as of 2021)

2.7 Date of Key Manufacturers Enter into Equine Influenza Vaccine Market

2.8 Key Manufacturers Equine Influenza Vaccine Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Equine Influenza Vaccine Status and Outlook by Region

3.1 Global Equine Influenza Vaccine Market Size and CAGR by Region: 2017 VS 2021 VS 2028

3.2 Global Equine Influenza Vaccine Historic Market Size by Region

3.2.1 Global Equine Influenza Vaccine Sales in Volume by Region (2017-2022)

3.2.2 Global Equine Influenza Vaccine Sales in Value by Region (2017-2022)

3.2.3 Global Equine Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2017-2022)

3.3 Global Equine Influenza Vaccine Forecasted Market Size by Region

3.3.1 Global Equine Influenza Vaccine Sales in Volume by Region (2023-2028)

3.3.2 Global Equine Influenza Vaccine Sales in Value by Region (2023-2028)

3.3.3 Global Equine Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2023-2028)

4 Global Equine Influenza Vaccine by Application

4.1 Equine Influenza Vaccine Market Segment by Application

4.1.1 Home

4.1.2 Pet Clinic

4.1.3 Others

4.2 Global Equine Influenza Vaccine Market Size by Application

4.2.1 Global Equine Influenza Vaccine Market Size Overview by Application (2017-2028)

4.2.2 Global Equine Influenza Vaccine Historic Market Size Review by Application (2017-2022)

4.2.2.1 Global Equine Influenza Vaccine Sales Breakdown in Volume, by Application (2017-2022)

4.2.2.2 Global Equine Influenza Vaccine Sales Breakdown in Value, by Application (2017-2022)

4.2.2.3 Global Equine Influenza Vaccine Average Selling Price (ASP) by Application (2017-2022)

4.2.3 Global Equine Influenza Vaccine Forecasted Market Size by Application (2023-2028)

4.2.3.1 Global Equine Influenza Vaccine Sales Breakdown in Volume, by Application (2023-2028)

4.2.3.2 Global Equine Influenza Vaccine Sales Breakdown in Value, by Application (2023-2028)

4.2.3.3 Global Equine Influenza Vaccine Average Selling Price (ASP) by Application (2023-2028)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Equine Influenza Vaccine Sales Breakdown by Application (2017-2022)

4.3.2 Europe Equine Influenza Vaccine Sales Breakdown by Application (2017-2022)

4.3.3 Asia-Pacific Equine Influenza Vaccine Sales Breakdown by Application (2017-2022)

4.3.4 Latin America Equine Influenza Vaccine Sales Breakdown by Application (2017-2022)

4.3.5 Middle East and Africa Equine Influenza Vaccine Sales Breakdown by Application (2017-2022)

5 North America Equine Influenza Vaccine by Country

5.1 North America Equine Influenza Vaccine Historic Market Size by Country

5.1.1 North America Equine Influenza Vaccine Sales in Volume by Country (2017-2022)

5.1.2 North America Equine Influenza Vaccine Sales in Value by Country (2017-2022)

5.2 North America Equine Influenza Vaccine Forecasted Market Size by Country

5.2.1 North America Equine Influenza Vaccine Sales in Volume by Country (2023-2028)

5.2.2 North America Equine Influenza Vaccine Sales in Value by Country (2023-2028)

6 Europe Equine Influenza Vaccine by Country

6.1 Europe Equine Influenza Vaccine Historic Market Size by Country

6.1.1 Europe Equine Influenza Vaccine Sales in Volume by Country (2017-2022)

6.1.2 Europe Equine Influenza Vaccine Sales in Value by Country (2017-2022)

6.2 Europe Equine Influenza Vaccine Forecasted Market Size by Country

6.2.1 Europe Equine Influenza Vaccine Sales in Volume by Country (2023-2028)

6.2.2 Europe Equine Influenza Vaccine Sales in Value by Country (2023-2028)

7 Asia-Pacific Equine Influenza Vaccine by Region

7.1 Asia-Pacific Equine Influenza Vaccine Historic Market Size by Region

7.1.1 Asia-Pacific Equine Influenza Vaccine Sales in Volume by Region (2017-2022)

7.1.2 Asia-Pacific Equine Influenza Vaccine Sales in Value by Region (2017-2022)

7.2 Asia-Pacific Equine Influenza Vaccine Forecasted Market Size by Region

7.2.1 Asia-Pacific Equine Influenza Vaccine Sales in Volume by Region (2023-2028)

7.2.2 Asia-Pacific Equine Influenza Vaccine Sales in Value by Region (2023-2028)

8 Latin America Equine Influenza Vaccine by Country

8.1 Latin America Equine Influenza Vaccine Historic Market Size by Country

8.1.1 Latin America Equine Influenza Vaccine Sales in Volume by Country (2017-2022)

8.1.2 Latin America Equine Influenza Vaccine Sales in Value by Country (2017-2022)

8.2 Latin America Equine Influenza Vaccine Forecasted Market Size by Country

8.2.1 Latin America Equine Influenza Vaccine Sales in Volume by Country (2023-2028)

8.2.2 Latin America Equine Influenza Vaccine Sales in Value by Country (2023-2028)

9 Middle East and Africa Equine Influenza Vaccine by Country

9.1 Middle East and Africa Equine Influenza Vaccine Historic Market Size by Country

9.1.1 Middle East and Africa Equine Influenza Vaccine Sales in Volume by Country (2017-2022)

9.1.2 Middle East and Africa Equine Influenza Vaccine Sales in Value by Country (2017-2022)

9.2 Middle East and Africa Equine Influenza Vaccine Forecasted Market Size by Country

9.2.1 Middle East and Africa Equine Influenza Vaccine Sales in Volume by Country (2023-2028)

9.2.2 Middle East and Africa Equine Influenza Vaccine Sales in Value by Country (2023-2028)

10 Company Profiles and Key Figures in Equine Influenza Vaccine Business

10.1 Zoetis

10.1.1 Zoetis Corporation Information

10.1.2 Zoetis Introduction and Business Overview

10.1.3 Zoetis Equine Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

10.1.4 Zoetis Equine Influenza Vaccine Products Offered

10.1.5 Zoetis Recent Development

10.2 Merck Animal Health

10.2.1 Merck Animal Health Corporation Information

10.2.2 Merck Animal Health Introduction and Business Overview

10.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

10.2.4 Merck Animal Health Equine Influenza Vaccine Products Offered

10.2.5 Merck Animal Health Recent Development

10.3 Boehringer Ingelheim Vetmedica

10.3.1 Boehringer Ingelheim Vetmedica Corporation Information

10.3.2 Boehringer Ingelheim Vetmedica Introduction and Business Overview

10.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

10.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Products Offered

10.3.5 Boehringer Ingelheim Vetmedica Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Equine Influenza Vaccine Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Equine Influenza Vaccine Industrial Chain Analysis

11.4 Equine Influenza Vaccine Market Dynamics

11.4.1 Equine Influenza Vaccine Industry Trends

11.4.2 Equine Influenza Vaccine Market Drivers

11.4.3 Equine Influenza Vaccine Market Challenges

11.4.4 Equine Influenza Vaccine Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Equine Influenza Vaccine Distributors

12.3 Equine Influenza Vaccine Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com